{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:11:26Z","timestamp":1786990286675,"version":"build-2736575974"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100006477","name":"National Taiwan University","doi-asserted-by":"publisher","award":["200801019R"],"award-info":[{"award-number":["200801019R"]}],"id":[{"id":"10.13039\/501100006477","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010002","name":"Ministry of Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["110-2113-M-002-006-MY3"],"award-info":[{"award-number":["110-2113-M-002-006-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.ijantimicag.2023.107028","type":"journal-article","created":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T20:11:38Z","timestamp":1699128698000},"page":"107028","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Enhancing the identification of voriconazole-associated hepatotoxicity by targeted metabolomics"],"prefix":"10.1016","volume":"63","author":[{"given":"Yi-Hsuan","family":"Chiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Ning","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Jiun","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yee-Chun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Jing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Hua","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9940-0850","authenticated-orcid":false,"given":"Shu-Wen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7441-9355","authenticated-orcid":false,"given":"Lin-Chau","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2023.107028_bib0001","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa020191","article-title":"Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis","volume":"347","author":"Herbrecht","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2023.107028_bib0002","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1111\/j.1469-0691.2011.03548.x","article-title":"Epidemiological trends in invasive aspergillosis in France: the SAIF network (2005-2007)","volume":"17","author":"Lortholary","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2023.107028_bib0003","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.2174\/13816128113199990330","article-title":"Invasive aspergillosis: new insights into disease, diagnostic and treatment","volume":"19","author":"Karthaus","year":"2013","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.ijantimicag.2023.107028_bib0004","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1111\/j.1600-6143.2012.04042.x","article-title":"Risk factors for voriconazole hepatotoxicity at 12 weeks in lung transplant recipients","volume":"12","author":"Luong","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ijantimicag.2023.107028_bib0005","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.bbmt.2009.08.015","article-title":"Hepatic safety of voriconazole after allogeneic hematopoietic stem cell transplantation","volume":"16","author":"Amigues","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.ijantimicag.2023.107028_bib0006","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1093\/mmy\/myaa008","article-title":"Reasons for voriconazole prophylaxis discontinuation in allogeneic hematopoietic cell transplant recipients: A real-life paradigm","volume":"58","author":"Chan","year":"2020","journal-title":"Med Mycol"},{"key":"10.1016\/j.ijantimicag.2023.107028_bib0007","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.jhep.2019.02.014","article-title":"EASL Clinical Practice Guidelines: Drug-induced liver injury","volume":"70","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.ijantimicag.2023.107028_bib0008","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1503\/cmaj.1040752","article-title":"Liver enzyme alteration: a guide for clinicians","volume":"172","author":"Giannini","year":"2005","journal-title":"CMAJ"},{"key":"10.1016\/j.ijantimicag.2023.107028_bib0009","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/ajg.2016.517","article-title":"ACG Clinical guideline: evaluation of abnormal liver chemistries","volume":"112","author":"Kwo","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ijantimicag.2023.107028_bib0010","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1111\/j.1572-0241.2000.03293.x","article-title":"An assessment of the role of liver biopsies in asymptomatic patients with chronic liver test abnormalities","volume":"95","author":"Sorbi","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ijantimicag.2023.107028_bib0011","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1093\/jac\/dku031","article-title":"Understanding variability with voriconazole using a population pharmacokinetic approach: implications for optimal dosing","volume":"69","author":"Dolton","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2023.107028_bib0012","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1086\/524669","article-title":"Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes","volume":"46","author":"Pascual","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.107028_bib0013","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1093\/cid\/cis599","article-title":"The effect of therapeutic drug monitoring on safety and efficacy of voriconazole in invasive fungal infections: a randomized controlled trial","volume":"55","author":"Park","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.107028_bib0014","doi-asserted-by":"crossref","first-page":"4793","DOI":"10.1128\/AAC.00626-12","article-title":"Multicenter study of voriconazole pharmacokinetics and therapeutic drug monitoring","volume":"56","author":"Dolton","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2023.107028_bib0015","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1093\/jac\/dkw099","article-title":"Utility of voriconazole therapeutic drug monitoring: a meta-analysis","volume":"71","author":"Luong","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2023.107028_bib0016","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1093\/jac\/dkw045","article-title":"Trough concentration of voriconazole and its relationship with efficacy and safety: a systematic review and meta-analysis","volume":"71","author":"Jin","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2023.107028_bib0017","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s10156-011-0363-6","article-title":"Investigation and threshold of optimum blood concentration of voriconazole: a descriptive statistical meta-analysis","volume":"18","author":"Hamada","year":"2012","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.ijantimicag.2023.107028_bib0018","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1007\/s40262-015-0297-8","article-title":"Therapeutic drug monitoring of voriconazole in the management of invasive fungal infections: a critical review","volume":"54","author":"Elewa","year":"2015","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ijantimicag.2023.107028_bib0019","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1517\/17425255.3.3.407","article-title":"Drug metabolite profiling and elucidation of drug-induced hepatotoxicity","volume":"3","author":"Tang","year":"2007","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.ijantimicag.2023.107028_bib0020","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/clpt.2010.151","article-title":"The application of metabonomics to predict drug-induced liver injury","volume":"88","author":"O'Connell","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ijantimicag.2023.107028_bib0021","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00204-013-1118-1","article-title":"Circulating acylcarnitines as biomarkers of mitochondrial dysfunction after acetaminophen overdose in mice and humans","volume":"88","author":"McGill","year":"2014","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.ijantimicag.2023.107028_bib0022","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.fct.2017.02.030","article-title":"Identification of urine tauro-\u03b2-muricholic acid as a promising biomarker in Polygoni Multiflori Radix-induced hepatotoxicity by targeted metabolomics of bile acids","volume":"108","author":"Zhao","year":"2017","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.ijantimicag.2023.107028_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2020.115157","article-title":"Metabolomics analysis of plasma reveals voriconazole-induced hepatotoxicity is associated with oxidative stress","volume":"403","author":"Wu","year":"2020","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.ijantimicag.2023.107028_bib0024","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3390\/ijms17010014","article-title":"RUCAM in drug and herb induced liver injury: the update","volume":"17","author":"Danan","year":"2015","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ijantimicag.2023.107028_bib0025","doi-asserted-by":"crossref","DOI":"10.3390\/metabo9050099","article-title":"Effects of long-term storage at -80 \u00b0C on the human plasma metabolome","volume":"9","author":"Wagner-Golbs","year":"2019","journal-title":"Metabolites"},{"key":"10.1016\/j.ijantimicag.2023.107028_bib0026","series-title":"Bioanalytical Method Validation","year":"2018"},{"key":"10.1016\/j.ijantimicag.2023.107028_bib0027","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate - a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J Royal Statist Soc"},{"key":"10.1016\/j.ijantimicag.2023.107028_bib0028","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/clpt.2011.58","article-title":"Case definition and phenotype standardization in drug-induced liver injury","volume":"89","author":"Aithal","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ijantimicag.2023.107028_bib0029","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jchromb.2005.08.016","article-title":"Differentiated quantification of human bile acids in serum by high-performance liquid chromatography-tandem mass spectrometry","volume":"826","author":"Burkard","year":"2005","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.ijantimicag.2023.107028_bib0030","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/toxsci\/kft221","article-title":"Evaluation of serum bile acid profiles as biomarkers of liver injury in rodents","volume":"137","author":"Luo","year":"2014","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.ijantimicag.2023.107028_bib0031","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s11274-020-02900-8","article-title":"Biochemical pathways to \u03b1-ketoglutarate, a multi-faceted metabolite","volume":"36","author":"Legendre","year":"2020","journal-title":"World J Microbiol Biotechnol"},{"key":"10.1016\/j.ijantimicag.2023.107028_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.devcel.2018.09.020","article-title":"Metabolic remodeling during liver regeneration","volume":"47","author":"Caldez","year":"2018","journal-title":"Dev Cell"},{"key":"10.1016\/j.ijantimicag.2023.107028_bib0033","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/clpt.2008.262","article-title":"Monitoring for hepatotoxicity: what is the predictive value of liver \"function\" tests?","volume":"85","author":"Senior","year":"2009","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ijantimicag.2023.107028_bib0034","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/sj.bjc.6605855","article-title":"The relationship between the presence and site of cancer, an inflammation-based prognostic score and biochemical parameters. Initial results of the Glasgow Inflammation Outcome Study","volume":"103","author":"Proctor","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ijantimicag.2023.107028_bib0035","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1128\/AAC.00251-13","article-title":"Potential factors for inadequate voriconazole plasma concentrations in intensive care unit patients and patients with hematological malignancies","volume":"57","author":"Hoenigl","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2023.107028_bib0036","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/jac\/dkt508","article-title":"Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology","volume":"69","author":"Ashbee","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2023.107028_bib0037","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.107028_bib0038","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/myc.13082","article-title":"Treatment of invasive fungal diseases in cancer patients-Revised 2019 Recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)","volume":"63","author":"Ruhnke","year":"2020","journal-title":"Mycoses"},{"key":"10.1016\/j.ijantimicag.2023.107028_bib0039","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.cca.2013.05.025","article-title":"Association of sustained high plasma trough concentration of voriconazole with the incidence of hepatotoxicity","volume":"424","author":"Suzuki","year":"2013","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.ijantimicag.2023.107028_bib0040","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3390\/metabo9050099","article-title":"Effects of Long-term storage at -80\u00b0C on the human plasma metabolome","volume":"9","author":"Wagner-Golbs","year":"2019","journal-title":"Metabolites"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857923003175?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857923003175?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T21:12:08Z","timestamp":1777583528000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857923003175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0924857923003175"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2023.107028","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhancing the identification of voriconazole-associated hepatotoxicity by targeted metabolomics","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2023.107028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd and International Society of Antimicrobial Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107028"}}